Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Msphere|April 5, 2023
A Novel Shigella O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella SerotypesGirmay Desalegn, Neeraj Kapoor, Lucy Pill-Pepe, et al.Mbio|February 25, 2016
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing AntibodiesZachary A Bornholdt, Esther Ndungo, Marnie L Fusco, et al.Mbio|April 16, 2025
Shigella humoral immunity during the first 2 years of life in children from endemic areasEsther Ndungo, Ushasi Bhaumik, Yuanyuan Liang, et al.Cell Reports|August 17, 2022
Systems approach to define humoral correlates of immunity to ShigellaBiana Bernshtein, Esther Ndungo, Deniz Cizmeci, et al.Frontiers in Immunology|November 1, 2021
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against ShigellosisEsther Ndungo, Liana R Andronescu, Andrea G Buchwald, et al.NPJ Vaccines|January 3, 2024
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidateGirmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit, et al.Virology|October 14, 2014
Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1Melinda Ng, Esther Ndungo, Rohit K Jangra, et al.Msphere|June 16, 2016
A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in ReptilesEsther Ndungo, Andrew S Herbert, Matthijs Raaben, et al.Msphere|August 3, 2018
A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengeEsther Ndungo, Arlo Randall, Tracy H Hazen, et al.Mbio|August 4, 2022
Mucosal Immune Profiles Associated with Diarrheal Disease Severity in Shigella- and Enteropathogenic Escherichia coli-Infected Children Enrolled in the Global Enteric Multicenter StudyAmanda D Buskirk, Esther Ndungo, Avital A Shimanovich, et al.Pageof 3